Novartis Q4 profit plummets on restructuring hit
Swiss drug giant Novartis saw its fourth-quarter net profit tumble 42% to £931 million, falling below analysts’ expectations, as restructuring costs and skinny US sales ate into earnings.
Read MoreAuthor: Selina McKee
NHS Alliance addresses integrated health services
The NHS Alliance has called on several organisations to pull together to help clinicians lead the looming integration of primary and secondary healthcare services.
Read MoreDouble win for Fostair with UK launch/SMC nod
It was a double-portion of good news for Trinity-Chiesi this week after the firm launched its promising new asthma treatment Fostair in the UK, and received a nod from the Scottish Medicines Consortium for its use on the National Health Service.
Read MoreCancer vaccines project gets £1.1m grant
The UK Technology Strategy Board has dished out £1.1 million to help fund a three-year project to develop predictive manufacturing tools for future cell-based cancer vaccines.
Read MoreCancer charities merge to boost services
Cancerbackup and Macmillan Cancer Support are to merge to “further the aims of both charities” and improve the delivery of high-quality information to patients with cancer.
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
